Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127864431 | 12786443 | 1 | I | 201605 | 20160516 | 20160927 | 20160927 | PER | US-FRI-1000084842 | ALLERGAN | 54.67 | YR | F | Y | 0.00000 | 20160927 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127864431 | 12786443 | 1 | PS | LINZESS | LINACLOTIDE | 1 | Oral | 290 ?G, QD | Y | U | A446506 | 202811 | 290 | UG | CAPSULE | QD | |||
| 127864431 | 12786443 | 2 | SS | LINZESS | LINACLOTIDE | 1 | 290 ?G, UNK | Y | U | A474347 | 202811 | 290 | UG | CAPSULE | |||||
| 127864431 | 12786443 | 3 | SS | SINEMET | CARBIDOPALEVODOPA | 1 | Oral | 25/100 THREE TIMES A DAY | 0 | ||||||||||
| 127864431 | 12786443 | 4 | SS | AZILECT | RASAGILINE MESYLATE | 1 | Oral | 1 MG, QD | 0 | 1 | MG | QD | |||||||
| 127864431 | 12786443 | 5 | SS | LEVOTHYROXINE SODIUM UNK | LEVOTHYROXINE SODIUM | 1 | Oral | 75 ?G, QD | 0 | 75 | UG | QD | |||||||
| 127864431 | 12786443 | 6 | SS | ZETIA | EZETIMIBE | 1 | Oral | 10 MG, QD | 0 | 10 | MG | QD | |||||||
| 127864431 | 12786443 | 7 | SS | METFORMIN HCL UNK | METFORMIN HYDROCHLORIDE | 1 | Oral | 1000 MG, QD | 0 | 1000 | MG | QD | |||||||
| 127864431 | 12786443 | 8 | C | MIRALAX | POLYETHYLENE GLYCOL 3350 | 1 | DAILY OR TWICE DAILY | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127864431 | 12786443 | 1 | Constipation |
| 127864431 | 12786443 | 3 | Parkinson's disease |
| 127864431 | 12786443 | 4 | Parkinson's disease |
| 127864431 | 12786443 | 5 | Thyroid disorder |
| 127864431 | 12786443 | 6 | Blood cholesterol increased |
| 127864431 | 12786443 | 7 | Diabetes mellitus |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127864431 | 12786443 | Abdominal distension | |
| 127864431 | 12786443 | Constipation | |
| 127864431 | 12786443 | Dizziness | |
| 127864431 | 12786443 | Drug effect decreased | |
| 127864431 | 12786443 | Drug ineffective | |
| 127864431 | 12786443 | Drug interaction | |
| 127864431 | 12786443 | Gait disturbance | |
| 127864431 | 12786443 | Gastrointestinal motility disorder | |
| 127864431 | 12786443 | Off label use | |
| 127864431 | 12786443 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127864431 | 12786443 | 1 | 201605 | 20160516 | 0 | |
| 127864431 | 12786443 | 2 | 201605 | 0 | ||
| 127864431 | 12786443 | 8 | 201605 | 0 |